Quick Summary •CMS Coverage: CMS has approved Medtronic’s renal denervation procedure for patients with resistant hypertension. •Innovation: This minimally invasive treatment targets kidney nerves to
Quick Summary Event: Neurogene’s stock fell 44% after reporting a severe adverse event in its high-dose gene therapy trial for Rett syndrome. Clinical Concern: The
Quick Summary Approval: The Centers for Medicare & Medicaid Services (CMS) now covers Medtronic’s renal denervation procedure for hypertension. Treatment: Renal denervation targets nerves in
Quick Summary FDA Approval: The FDA has granted clearance for LumiThera’s Valeda system, the first treatment approved for dry age-related macular degeneration (AMD). Technology: The
Quick Summary Acquisition Value: $350 million Strategic Focus: Expanding Hologic’s gynecology portfolio, specifically in minimally invasive surgical solutions. Impact: Strengthens Hologic’s offering in women’s health
Quick Summary Focus: Nanocube Health Ltd. is developing nanorobots for diagnosing and treating hard-to-detect cancers. Initial Target: Pancreatic cancer, known for its high mortality and
Quick Summary IPO Details: Ceribell launched its IPO at $17 per share, closing above $25. Technology Focus: Portable EEG system for emergency and ICU use.
Quick Summary Focus: Onward Medical licenses a brain-computer interface (BCI) chip from CEA-Clinatec. Goal: Enable spinal cord injury patients to regain communication between brain and
Quick Summary Device: Embecta’s new disposable insulin patch pump with a 300-unit reservoir. FDA Clearance: Approved as a tubeless insulin delivery system for both Type
Quick Summary Partnership Focus: Nvidia, Amgen’s deCode Genetics, and Recursion Pharmaceuticals collaborate to harness AI in drug discovery. Platform: Nvidia’s BioNeMo platform will be used
